Tirzepatide and Heart Outcomes: What SURPASS-CVOT Shows 6th June 202626th March 2026 by Living Diabetes Editorial Team SURPASS-CVOT compared tirzepatide with dulaglutide in type 2 diabetes and ASCVD. Learn what the result does and does not prove.
GLP-1 Medications and Heart Protection: What the Evidence Shows 6th June 202619th March 2026 by Living Diabetes Editorial Team Some GLP-1 medicines have heart outcome benefits in type 2 diabetes, but evidence is medication-specific. Learn the main caveats.
Muscle Loss on GLP-1 Medicines: How to Preserve Lean Mass 6th June 202618th March 2026 by Living Diabetes Editorial Weight loss on GLP-1 medicines can include lean mass. Learn how protein, strength training, monitoring, and safety planning fit.
Oral Semaglutide (Rybelsus): What Adults With Type 2 Diabetes Should Know 6th June 202615th March 2026 by Living Diabetes Editorial Oral semaglutide is a GLP-1 medicine for adults with type 2 diabetes. Learn timing rules, safety cautions, and questions to ask.
New Research Confirms GLP-1 Medications Protect the Heart, Not Just Blood Sugar 6th June 202629th November 2025 by Living Diabetes Editorial New Research Confirms GLP-1 Medications Protect the Heart, Not Just Blood Sugar: cardiovascular outcome trial evidence, who benefits most, and how this drug.
Ozempic Side Effects and Warnings: What to Know 6th June 202623rd September 2023 by Living Diabetes Editorial Ozempic can help some adults with type 2 diabetes, but side effects and warnings matter. Learn what to discuss before use.
Ozempic for Type 2 Diabetes: Benefits, Side Effects, and Safety 6th June 202623rd February 2023 by Living Diabetes Editorial Ozempic is a semaglutide medicine for type 2 diabetes. Learn expected benefits, common side effects, warnings, and care-team questions.
